SMTL ID : 6xkq.1

Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CV07-250

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.55 Å

Oligo State

hetero-1-1-1-mer

Ligands

2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.1: 5 residues within 4Å: Chain A: F.20, G.21, F.24, N.25, L.50 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:F.24, A:L.50 Hydrogen bonds: A:N.25 NAG.2: 5 residues within 4Å: Chain B: N.28, T.30, T.74, S.75, T.77 4 PLIP interactions: 4 interactions with chain B Hydrophobic interactions: B:T.77 Hydrogen bonds: B:N.28, B:T.30, B:S.75

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kreye, J. et al., A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model. Cell (2020)

Release Date

2020-10-14

Peptides

Spike protein S1: A
CV07-250 Heavy Chain: B
CV07-250 Light Chain: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
H

C
L

Spike protein S1

CV07-250 Heavy Chain

CV07-250 Light Chain

Related Entries With Identical Sequence